U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07419854) titled 'Restoring Facial Volume After GLP-1 Weight Loss With Radiesse' on Jan. 30.
Brief Summary: The goal of this clinical trial is to evaluate the potential of Calcium Hydroxylapatite (CaHA) to restore facial volume and improve skin quality in patients with GLP-1 receptor agonist-associated facial volume loss. Participants will:
* Schedule first dose of a prescribed GLP-1 receptor agonist drug to coincide with the baseline visit of this study
* Be randomly assigned to one of two groups (Group A will receive off-label injections of hyperdiluted CaHA at Month 0. Group B will receive on-label injections of CaHA after serving as a control g...